Bank of New York Mellon Corp - FURIEX PHARMACEUTICALS INC ownership

FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 85 filers reported holding FURIEX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$7,898,000
+63.0%
74,376
+33.6%
0.00%0.0%
Q1 2014$4,844,000
+31.5%
55,675
-36.5%
0.00%0.0%
Q4 2013$3,685,000
-48.9%
87,733
-46.5%
0.00%0.0%
Q3 2013$7,214,000
+187.3%
164,008
+122.5%
0.00%0.0%
Q2 2013$2,511,00073,7220.00%
Other shareholders
FURIEX PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
PRELUDE CAPITAL MANAGEMENT, LLC 10,000$375,0000.07%
SEGALL BRYANT & HAMILL, LLC 26,294$986,0000.03%
CREDIT SUISSE AG/ 87,053$3,262,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 12,765$478,0000.00%
Lehman Financial Resources, Inc. 50$2,0000.00%
View complete list of FURIEX PHARMACEUTICALS INC shareholders